Federal OSHA · osha.gov
Program-Based Standards

Bloodborne Pathogens Medical Surveillance

Occupational exposure to blood/OPIM risks HBV, HCV, and HIV transmission; affects healthcare, laboratory, custodial, first-responder, and other workers with reasonably anticipated exposure.

Who is covered: All employees with reasonably anticipated occupational exposure to blood or other potentially infectious materials (OPIM). The standard reaches exposed workers across general industry and is applied to exposed construction workers as well (no GI/construction split for the medical provisions).

Evaluation performed by: Licensed physician or other licensed healthcare professional

🩺 Baseline / Pre-Placement

Hepatitis B vaccination made available within 10 working days of initial assignment to all employees with occupational exposure (after required training) — 1910.1030(f)(2)(i)

  • Hepatitis B vaccine and full vaccination series MADE AVAILABLE at no cost (unless previously vaccinated, immune by antibody testing, or contraindicated) — 1910.1030(f)(1)(i)
  • Performed by or under the supervision of a licensed physician or other licensed healthcare professional, per current USPHS recommendations — 1910.1030(f)(1)(ii)
  • No antibody prescreening may be required as a condition of receiving vaccination — 1910.1030(f)(2)(ii)
  • If the employee declines, a signed Hepatitis B Vaccine Declination statement (Appendix A) — 1910.1030(f)(2)(iv)
  • If USPHS later recommends routine booster doses, they must be made available — 1910.1030(f)(1)(ii)
Abnormal results & exposure-event protocols

Abnormal Results & Exposure-Event Protocols

  • An EXPOSURE INCIDENT (specific eye, mouth, mucous-membrane, non-intact skin, or parenteral contact with blood/OPIM) 1910.1030(f)(3): Make immediately available a confidential post-exposure medical evaluation and follow-up: document route(s) and circumstances; identify and test the SOURCE individual's blood for HBV and HIV as soon as feasible (consent obtained, or where law allows without consent; not repeated if source already known infected); collect the EXPOSED employee's blood as soon as feasible and test after consent (if the employee declines HIV testing, the sample is preserved at least 90 days for later testing on request); provide post-exposure prophylaxis when medically indicated per USPHS; provide counseling and evaluation of reported illnesses. Tests: Documentation of route(s) of exposure and circumstances — 1910.1030(f)(3)(i), Source-individual blood testing for HBV and HIV infectivity (as soon as feasible) — 1910.1030(f)(3)(ii), Exposed-employee baseline blood collection and testing after consent; sample preserved ≥90 days if HIV testing declined — 1910.1030(f)(3)(iii), Post-exposure prophylaxis when medically indicated per USPHS — 1910.1030(f)(3)(iv), Counseling and evaluation of reported illnesses — 1910.1030(f)(3)(v)-(vi), Information provided to the evaluating healthcare professional: copy of the standard, employee's duties, route/circumstances, source test results, relevant medical records — 1910.1030(f)(4)(ii)

Reporting Requirements

Who performs the evaluationLicensed physician or other licensed healthcare professional (HBV vaccination performed by or under the supervision of a licensed physician/healthcare professional; post-exposure evaluation by a licensed healthcare professional) — 1910.1030(f)(1)(ii), (f)(3).
Reported to employerEmployer receives the healthcare professional's WRITTEN OPINION, limited to: (HBV) whether vaccination is indicated and whether the employee has received it; (post-exposure) that the employee was informed of evaluation results and of any medical condition resulting from the exposure that requires further evaluation or treatment. ALL OTHER findings/diagnoses remain confidential and are NOT in the written report — 1910.1030(f)(5).
Reported to / for the employeeEmployer provides the employee a copy of the healthcare professional's written opinion; post-exposure evaluation results communicated to the employee — 1910.1030(f)(5).
Time limitsEmployer provides the written opinion to the employee within 15 days of completion of the evaluation — 1910.1030(f)(5)(i).
RecordkeepingConfidential medical records (HBV status, post-exposure evaluation/testing results, written opinions, info provided to the healthcare professional) retained for the DURATION of employment PLUS 30 YEARS; not disclosed without the employee's written consent — 1910.1030(h)(1).

Medical Removal Protection

No MRP. The program is vaccination + post-exposure evaluation/follow-up (see abnormal_protocols). No routine periodic surveillance schedule; HBV is a one-time series (boosters only if USPHS later recommends).

How this compares to Cal/OSHA: California 8 CCR 5193 names HCV EXPLICITLY in the post-exposure source-testing panel (alongside HBV and HIV), whereas federal 1910.1030(f)(3)(ii) enumerates HBV and HIV (HCV handled via USPHS-guided follow-up) — both result in HBV/HCV/HIV management but California's text is more explicit. California additionally maintains a separate Aerosol Transmissible Diseases standard (8 CCR 5199) covering airborne pathogens, with no federal equivalent. Vaccination timing (10 working days), the 15-day written-opinion limit, and duration+30-year record retention are the same.

Occu-Med handles Bloodborne Pathogens surveillance end-to-end

Scheduling, exams, lab panels, physician review, removal/return determinations, and audit-ready recordkeeping — fully compliant with Federal OSHA requirements.